<DOC>
	<DOCNO>NCT00879970</DOCNO>
	<brief_summary>This study answer two separate question . The first question test cardiovascular effect long-term treatment rosiglitazone pioglitazone use part standard care compare similar standard care without rosiglitazone pioglitazone patient type 2 diabetes history risk cardiovascular disease . The second question compare effect long-term supplementation vitamin D death cancer</brief_summary>
	<brief_title>Thiazolidinedione Intervention With Vitamin D Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>2,4-thiazolidinedione</mesh_term>
	<criteria>Men woman : ) newly detect type 2 diabetes base fast plasma glucose great equal 7.0 mmol/l ( 126 mg/dL ) 2 hour plasma glucose ( FPG ) great equal 11.1 mmol/l ( 200 mg/dL ) oral glucose tolerance test , b ) history type 2 diabetes Hemoglobin A1c ( A1C ) 6.59.5 % inclusive ( assays upper limit normal 6 % ) within one month screen Age ≥ 50 year evidence vascular disease define ≥1of : prior myocardial infarction prior stroke coronary , carotid peripheral artery revascularization ≥ 4 year earlier previous document myocardial ischemia either exercise stress test cardiac imaging , previous unstable angina ECG change cardiac enzyme elevation OR Age ≥ 55 year evidence subclinical vascular disease define ≥1 : microalbuminuria proteinuria history treat untreated hypertension leave ventricular hypertrophy electrocardiogram ( ECG ) echocardiogram 50 % stenosis image coronary , carotid low extremity artery ankle/brachial index &lt; 0.9 OR Age ≥ 60 year least 2 follow cardiovascular disease risk factor : current tobacco use LDLc ≥3.4 mmol/L ( 130 mg/dL ) lipid lower medication HDLc &lt; 1.0 mmol/L ( 40 mg/dL ) men &lt; 1.3 mmol/L ( 50 mg/dL ) woman triglycerides ≥ 2.3 mmol/L ( 200 mg/dL ) BP lower medication use untreated SBP ≥ 140 mmHg DBP ≥ 95 mmHg Waist hip ratio &gt; 1.0 men &gt; 0.8 woman On insulin le equal 2 antidiabetes drug least one drug halfmaximal dose ( indicated MOP ) stable dose 10 week prior screen Type 1 diabetes Current need insulin treatment Symptomatic hyperglycemia require immediate therapy judgment physician An acute cardiovascular event within 30 day prior randomization Symptomatic heart failure ( i.e . New York Heart Association class II high ) episode previous pulmonary edema know ejection fraction &lt; 0.4 current use loop diuretic Any fracture within past 1 year Currently plan coronary , carotid peripheral artery revascularization cardiac valve surgery Coronary , carotid peripheral artery revascularization within 4 year prior screen absence angina , MI , stroke intervene period End stage renal disease require renal replacement therapy Receiving drug therapy treat liver disease A diagnosis cancer ( superficial squamous , basal cell skin cancer , adequately treated cervical carcinoma situ ) past 3 year current treatment active cancer ( prophylactic ) Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) level &gt; 2.5 time upper limit normal A prior heart transplant await heart transplant Previous current hypercalcemia , hyperparathyroidism , osteomalacia contraindication vitamin D therapy Regular use indication great 400IU vitamin D daily Clinically medically unstable expect survival &lt; 1 year Unwillingness permit sit contact primary physician communicate information study participant 's data Any factor likely limit protocol compliance report adverse event Inability discontinue TZD ( take one ) judgement physician/investigator Contraindications history hypersensitivity investigational product History renal stone within past 2 year Participation another clinical trial investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cardiovascular Outcomes</keyword>
</DOC>